Suzan N. Kucukarslan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Suzan N. Kucukarslan has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Leslie A. Shimp
College of Pharmacy, University of Michigan, Ann Arbor, USA
4 shared publicationsCaroline A. Gaither
3 shared publicationsDuane M. Kirking
Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
2 shared publicationsNancy J. W. Lewis
2 shared publicationsNancy J.W. Lewis
Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
2 shared publicationsAbraham Bazzi
University of Michigan
1 shared publication
Latest Publications
- 1 November 2012
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 52 (6) , 768-776
Employer-based patient-centered medication therapy management program: Evidence and recommendations for future programs
- 1 November 2012
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 52 (6) , 768-776
Employer-based patient-centered medication therapy management program: Evidence and recommendations for future programs
- 1 September 2012
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 8 (5) , 371-382
A review of published studies of patients’ illness perceptions and medication adherence: Lessons learned and future directions
- 1 September 2012
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 8 (5) , 371-382
A review of published studies of patients’ illness perceptions and medication adherence: Lessons learned and future directions
- 1 July 2012
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 8 (4) , 321-332
Exploring patient experiences with prescription medicines to identify unmet patient needs: Implications for research and practice
- 1 July 2012
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 8 (4) , 321-332
Exploring patient experiences with prescription medicines to identify unmet patient needs: Implications for research and practice
- 1 May 2012
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 52 (3) , 333-341
Patient desire to be involved in medication treatment decisions
- 1 May 2012
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 52 (3) , 333-341
Patient desire to be involved in medication treatment decisions
- 1 September 2011
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 7 (3) , 224-232
Physician beliefs and attitudes toward collaboration with community pharmacists
- 1 September 2011
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 7 (3) , 224-232
Physician beliefs and attitudes toward collaboration with community pharmacists
- 15 February 2011
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 68 (4) , 335-345
Integrating medication therapy management in the primary care medical home: A review of randomized controlled trials
Purpose Randomized controlled trials (RCTs) that evaluated the effect of medication therapy management (MTM) on patient outcomes in the primary care medical home were reviewed to determine how these services may be integrated into the primary care medical home. Methods A literature search was conducted to identify RCTS published between 1989 and 2009 that evaluated the impact of MTM services on patient outcomes. To qualify as MTM services, the interventions had to include both a review of medication therapy and patient interactions, including educating patients about drug therapy, identifying potential barriers to medication adherence, and helping patients manage their diseases. The internal validity of the studies was evaluated using previously published criteria. The description, specification, and appropriateness of study objectives, study population, intervention, randomization, blinding, outcome measures, statistical analysis, and conclusions were evaluated. Results A total of 1795 publications were identified, but only 8 met the inclusion criteria. These studies targeted patients with specific medical conditions or patients with multiple medications without specifying a medical condition. The interventions varied in intensity (i.e., frequency and length of patient contact), ranging from a single patient contact in a community pharmacy setting to multiple visits with an ambulatory care pharmacist practicing in a collaborative care model. Two of the 8 studies obtained expected results. These studies targeted patients with unrealized therapeutic goals, and the interventions involved collaboration between pharmacists and physicians and extensive patient follow-up. Conclusion Of 1795 publications identified, 8 were RCTs meeting selection criteria for evaluation of the effect of MTM services on patient outcomes. Two service elements that benefit patient care were identified: (1) selecting patients with specific therapeutic problems and (2) implementing MTM services that involve timely communication with primary care providers to discuss therapeutic problems, along with routine patient follow-up to support medication adherence to changes in therapy.
- 15 February 2011
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 68 (4) , 335-345
Integrating medication therapy management in the primary care medical home: A review of randomized controlled trials
Purpose Randomized controlled trials (RCTs) that evaluated the effect of medication therapy management (MTM) on patient outcomes in the primary care medical home were reviewed to determine how these services may be integrated into the primary care medical home. Methods A literature search was conducted to identify RCTS published between 1989 and 2009 that evaluated the impact of MTM services on patient outcomes. To qualify as MTM services, the interventions had to include both a review of medication therapy and patient interactions, including educating patients about drug therapy, identifying potential barriers to medication adherence, and helping patients manage their diseases. The internal validity of the studies was evaluated using previously published criteria. The description, specification, and appropriateness of study objectives, study population, intervention, randomization, blinding, outcome measures, statistical analysis, and conclusions were evaluated. Results A total of 1795 publications were identified, but only 8 met the inclusion criteria. These studies targeted patients with specific medical conditions or patients with multiple medications without specifying a medical condition. The interventions varied in intensity (i.e., frequency and length of patient contact), ranging from a single patient contact in a community pharmacy setting to multiple visits with an ambulatory care pharmacist practicing in a collaborative care model. Two of the 8 studies obtained expected results. These studies targeted patients with unrealized therapeutic goals, and the interventions involved collaboration between pharmacists and physicians and extensive patient follow-up. Conclusion Of 1795 publications identified, 8 were RCTs meeting selection criteria for evaluation of the effect of MTM services on patient outcomes. Two service elements that benefit patient care were identified: (1) selecting patients with specific therapeutic problems and (2) implementing MTM services that involve timely communication with primary care providers to discuss therapeutic problems, along with routine patient follow-up to support medication adherence to changes in therapy.
- 1 December 2009
- Published by Springer Nature in The Patient - Patient-Centered Outcomes Research
- Vol. 2 (4) , 211-220
Using Self-Regulation Theory to Examine Patient Goals, Barriers, and Facilitators for Taking Medication
Background: Self-regulation theory predicts that patient behavior is determined by the patient’s assessment of his/her condition (illness presentation) and related health goals. Patients will adapt their behavior to achieve those goals. However, there are multiple levels of goals. In such cases, those lower-level goals (health goals) that are strongly correlated with higher-level goals (i.e. quality of life [QOL]) are more likely to drive patient behavior. Medication non-compliance is a health behavior that challenges healthcare practitioners. Thus, the primary aim of this paper is to explore the relationship between the lower-level goals for taking medication with higher-level goals. This paper also identifies patient-perceived barriers and facilitators toward achieving goals as they may relate to patients’ illness representation. Objectives: To identify lower- and higher-level goals associated with medication use for chronic conditions. To determine if there is a relationship between higher-level (global) goals and lower-level (health-related) goals. To identify patient-perceived facilitators and barriers to achieving those goals. Methods: This was a prospective, observational study using a mailed survey. The setting was a US Midwestern state-wide survey. Participants were patients living in the community with hypertension, heart disease, diabetes mellitus, or arthritis, and taking prescription medication for any one of those conditions. The main outcome measures were lower- and higher-level goals related to medication use. The survey asked the participants if they had achieved their goals and to identify factors that may pose as barriers or facilitators to achieving them. Pearson correlation was used to test the relationship between the lower- and higher-level goals at p < 0.05. Results: Responses from 292 qualifying patients were obtained. A significant relationship between lower- and higher-level goals existed (p = 0.03). Preventing future health problems was the most important lower-level goal for almost half of the respondents. Approximately 43% of the respondents said ‘improving or maintaining quality of life’ was their most important higher-level goal. Elderly respondents (65 years or older) said that being able to carry out daily activities on their own was their most important higher-level goal. To achieve this goal, they identified ‘preventing future health problems’ as the associated lower-level goal. One-third of the respondents stated that they had not yet achieved their medication-related goals. Patients identified good communication with their physicians (35%), the effectiveness of the drug product (32%), and their ability to monitor their condition (20%) as important factors toward helping them achieve their goals. Medication costs (30%), drug adverse effects (25%), and the lack of drug effectiveness (22%) were factors that patients identified as barriers to achieving their goals. Conclusion: There is a significant and positive relationship between the lower- and higher-level goals. Healthcare providers can work with their patients to achieve their goals. Both good communication with the prescriber and the effectiveness of the drug product were identified as the most important facilitator by one-third of the respondents. Future research should study if relating the impact of good symptom control or the reduction of future health risks to QOL or longevity, as deemed relevant by the patient, influences medication adherence behavior.
- 1 December 2009
- Published by Springer Nature in The Patient - Patient-Centered Outcomes Research
- Vol. 2 (4) , 211-220
Using Self-Regulation Theory to Examine Patient Goals, Barriers, and Facilitators for Taking Medication
Background: Self-regulation theory predicts that patient behavior is determined by the patient’s assessment of his/her condition (illness presentation) and related health goals. Patients will adapt their behavior to achieve those goals. However, there are multiple levels of goals. In such cases, those lower-level goals (health goals) that are strongly correlated with higher-level goals (i.e. quality of life [QOL]) are more likely to drive patient behavior. Medication non-compliance is a health behavior that challenges healthcare practitioners. Thus, the primary aim of this paper is to explore the relationship between the lower-level goals for taking medication with higher-level goals. This paper also identifies patient-perceived barriers and facilitators toward achieving goals as they may relate to patients’ illness representation. Objectives: To identify lower- and higher-level goals associated with medication use for chronic conditions. To determine if there is a relationship between higher-level (global) goals and lower-level (health-related) goals. To identify patient-perceived facilitators and barriers to achieving those goals. Methods: This was a prospective, observational study using a mailed survey. The setting was a US Midwestern state-wide survey. Participants were patients living in the community with hypertension, heart disease, diabetes mellitus, or arthritis, and taking prescription medication for any one of those conditions. The main outcome measures were lower- and higher-level goals related to medication use. The survey asked the participants if they had achieved their goals and to identify factors that may pose as barriers or facilitators to achieving them. Pearson correlation was used to test the relationship between the lower- and higher-level goals at p < 0.05. Results: Responses from 292 qualifying patients were obtained. A significant relationship between lower- and higher-level goals existed (p = 0.03). Preventing future health problems was the most important lower-level goal for almost half of the respondents. Approximately 43% of the respondents said ‘improving or maintaining quality of life’ was their most important higher-level goal. Elderly respondents (65 years or older) said that being able to carry out daily activities on their own was their most important higher-level goal. To achieve this goal, they identified ‘preventing future health problems’ as the associated lower-level goal. One-third of the respondents stated that they had not yet achieved their medication-related goals. Patients identified good communication with their physicians (35%), the effectiveness of the drug product (32%), and their ability to monitor their condition (20%) as important factors toward helping them achieve their goals. Medication costs (30%), drug adverse effects (25%), and the lack of drug effectiveness (22%) were factors that patients identified as barriers to achieving their goals. Conclusion: There is a significant and positive relationship between the lower- and higher-level goals. Healthcare providers can work with their patients to achieve their goals. Both good communication with the prescriber and the effectiveness of the drug product were identified as the most important facilitator by one-third of the respondents. Future research should study if relating the impact of good symptom control or the reduction of future health risks to QOL or longevity, as deemed relevant by the patient, influences medication adherence behavior.
- 31 October 2008
- Published by Elsevier in Epilepsy & Behavior
- Vol. 13 (3) , 449-453
Patient-perceived risk associated with epilepsy and its medication treatment
- 31 October 2008
- Published by Elsevier in Epilepsy & Behavior
- Vol. 13 (3) , 449-453
Patient-perceived risk associated with epilepsy and its medication treatment
- 1 March 2008
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 4 (1) , 12-22
Evaluating medication-related services in a hospital setting using the disconfirmation of expectations model of satisfaction
- 1 March 2008
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 4 (1) , 12-22
Evaluating medication-related services in a hospital setting using the disconfirmation of expectations model of satisfaction